Bafna Pharmaceuticals standalone net profit rises 93.68% in the December 2025 quarter
Sales rise 15.37% to Rs 38.29 crore
Net profit of Bafna Pharmaceuticals rose 93.68% to Rs 1.84 crore in the quarter ended December 2025 as against Rs 0.95 crore during the previous quarter ended December 2024. Sales rose 15.37% to Rs 38.29 crore in the quarter ended December 2025 as against Rs 33.19 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var.Sales38.2933.19 15 OPM %7.979.25 -PBDT3.412.62 30 PBT1.840.96 92 NP1.840.95 94Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 12 2026 | 9:06 AM IST